What antibiotic is recommended for treating sinusitis and otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Sinusitis and Otitis Media

For both acute bacterial sinusitis and acute otitis media, amoxicillin-clavulanate is the preferred first-line antibiotic, with high-dose amoxicillin as an acceptable alternative in uncomplicated cases without recent antibiotic exposure. 1, 2

First-Line Treatment Recommendations

For Adults with Sinusitis

Mild disease without recent antibiotic use (past 4-6 weeks):

  • Amoxicillin-clavulanate (1.75-4 g/250 mg per day) is preferred 1, 2
  • High-dose amoxicillin (1.5-4 g/day) is acceptable for uncomplicated cases 1
  • Alternative cephalosporins: cefpodoxime proxetil, cefuroxime axetil, or cefdinir 1

Moderate disease OR recent antibiotic exposure:

  • High-dose amoxicillin-clavulanate (4 g/250 mg per day) is strongly recommended 1, 2
  • Respiratory fluoroquinolones (levofloxacin, moxifloxacin) are alternatives but should be reserved to avoid promoting resistance 1

For Children with Sinusitis

Mild disease without recent antibiotic use:

  • High-dose amoxicillin-clavulanate (90 mg/6.4 mg per kg per day) is first-line 1
  • High-dose amoxicillin (90 mg/kg per day) for uncomplicated cases 1
  • Alternative cephalosporins: cefdinir (preferred for palatability), cefpodoxime proxetil, or cefuroxime axetil 1

Moderate disease OR recent antibiotic exposure:

  • High-dose amoxicillin-clavulanate (90 mg/6.4 mg per kg per day) is mandatory 1

For Acute Otitis Media

First-choice for all ages:

  • Amoxicillin is the WHO-recommended first-line agent 1
  • Amoxicillin-clavulanate is the second-choice option 1
  • Standard amoxicillin dosing demonstrated 87% cure rates in pediatric otitis media trials 3

Treatment Duration

  • Sinusitis: 7-10 days is standard, though some experts recommend continuing until symptom-free plus an additional 7 days 2, 4
  • Otitis media: 10 days is the established duration 3
  • Reassess at 72 hours; if no improvement, switch antibiotics 1, 4

Penicillin-Allergic Patients

For non-severe (Type IV) reactions:

  • Second-generation cephalosporins (cefuroxime axetil) or third-generation (cefpodoxime, cefdinir) are safe alternatives 1, 2
  • Cefdinir is preferred in children due to better acceptance 1

For severe Type I hypersensitivity:

  • TMP-SMX, doxycycline, or macrolides (azithromycin, clarithromycin) can be used, but expect 20-25% bacteriologic failure rates 1
  • Clindamycin covers S. pneumoniae well (~90% susceptibility) but has no activity against H. influenzae or M. catarrhalis 1

High-Risk Situations Requiring Aggressive Therapy

Use high-dose amoxicillin-clavulanate when:

  • Recent antibiotic use within 4-6 weeks 1
  • Daycare attendance (children) 1
  • Age <2 years with bilateral otitis media 1
  • Immunodeficiency or frequent antibiotic exposure 1
  • Geographic areas with high penicillin-resistant S. pneumoniae prevalence 1

The rationale is that these factors increase risk for drug-resistant S. pneumoniae (DRSP), β-lactamase-producing H. influenzae, and M. catarrhalis 1.

Switch Therapy at 72 Hours

If no improvement after 3 days:

  • If started on amoxicillin alone → switch to high-dose amoxicillin-clavulanate 1, 4
  • If started on amoxicillin-clavulanate → switch to respiratory fluoroquinolone OR ceftriaxone (1 g/day IM/IV for 5 days in adults; 50 mg/kg/day in children) 1
  • Consider combination therapy: high-dose amoxicillin or clindamycin PLUS cefixime 1

Critical Pitfalls to Avoid

Do not use fluoroquinolones as first-line therapy - they should be reserved for treatment failures or penicillin-allergic patients to prevent resistance development, particularly in gut organisms 1, 2

Do not treat viral rhinosinusitis with antibiotics - antibiotics are only indicated when symptoms persist >10 days, are severe (high fever with purulent discharge for 3-4 days), or worsen after initial improvement 2, 5

Avoid macrolides as monotherapy - bacteriologic failure rates of 20-25% are common due to S. pneumoniae resistance, and azithromycin has poor activity against H. influenzae despite lack of formal resistance 1

Do not underdose amoxicillin-clavulanate - when treating DRSP risk, the high-dose regimen (4 g/250 mg in adults; 90 mg/6.4 mg per kg in children) is essential for adequate pharmacodynamic coverage 1

Watchful waiting is appropriate for otitis media - unless the child is <2 years with bilateral disease, a 2-3 day observation period with symptomatic treatment is reasonable before initiating antibiotics 1

Special Considerations

Chronic or recurrent sinusitis (≥3 episodes per year):

  • Evaluate for underlying allergies, immunodeficiency, and anatomic abnormalities 2
  • Consider referral to allergist-immunologist or otolaryngologist 2

Complicated sinusitis with meningeal signs, exophthalmos, or severe pain:

  • Requires hospitalization, cultures, and parenteral antibiotics 2

Adjunctive therapies:

  • Intranasal corticosteroids are beneficial, particularly in chronic hyperplastic eosinophilic rhinosinusitis 2
  • Topical decongestants may help but limit use to <3-5 days to avoid rebound rhinitis medicamentosa 2, 4
  • Antihistamines are NOT recommended for acute bacterial sinusitis but may help chronic sinusitis if allergic rhinitis is present 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Beginning antibiotics for acute rhinosinusitis and choosing the right treatment.

Clinical reviews in allergy & immunology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.